These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Multimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Colloby SJ, Cromarty RA, Peraza LR, Johnsen K, Jóhannesson G, Bonanni L, Onofrj M, Barber R, O'Brien JT, Taylor JP. J Psychiatr Res; 2016 Jul; 78():48-55. PubMed ID: 27060340 [Abstract] [Full Text] [Related]
11. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. Mueller SG, Schuff N, Weiner MW. NMR Biomed; 2006 Oct; 19(6):655-68. PubMed ID: 16986115 [Abstract] [Full Text] [Related]
12. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR. Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521 [Abstract] [Full Text] [Related]
13. Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies. Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire AM, O'Brien JT. Neuroimage Clin; 2015 Mar; 7():456-62. PubMed ID: 25685712 [Abstract] [Full Text] [Related]
14. Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis. Teipel SJ, Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K, EDSD study group. J Alzheimers Dis; 2014 Mar; 41(1):69-83. PubMed ID: 24577476 [Abstract] [Full Text] [Related]
15. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. Selnes P, Aarsland D, Bjørnerud A, Gjerstad L, Wallin A, Hessen E, Reinvang I, Grambaite R, Auning E, Kjærvik VK, Due-Tønnessen P, Stenset V, Fladby T. J Alzheimers Dis; 2013 Mar; 33(3):723-36. PubMed ID: 23186987 [Abstract] [Full Text] [Related]
16. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Kamagata K, Nakatsuka T, Sakakibara R, Tsuyusaki Y, Takamura T, Sato K, Suzuki M, Hori M, Kumamaru KK, Inaoka T, Aoki S, Terada H. Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426 [Abstract] [Full Text] [Related]
17. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK, Larsen JP, Aarsland D. Neurology; 2007 Aug 21; 69(8):747-54. PubMed ID: 17709706 [Abstract] [Full Text] [Related]
18. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Neurology; 2005 Mar 08; 64(5):861-5. PubMed ID: 15753423 [Abstract] [Full Text] [Related]
19. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images. Fu JL, Zhang T, Chang C, Zhang YZ, Li WB. Acta Radiol; 2012 Apr 01; 53(3):312-7. PubMed ID: 22416261 [Abstract] [Full Text] [Related]
20. Subcortical volume changes in dementia with Lewy bodies and Alzheimer's disease. A comparison with healthy aging. Watson R, Colloby SJ, Blamire AM, O'Brien JT. Int Psychogeriatr; 2016 Apr 01; 28(4):529-36. PubMed ID: 26572170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]